Share. Connect. Create. Grow. · Socialiya
Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide

(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generatio...

BUSINESS NEWS July 25, 2026

Eli Lilly delays FDA filing for next-generation weight-loss drug retatrutide

(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generation weight-loss drug, retatrutide, following positive...

13 views 0 likes 0 comments
Share:
(NewsNation) — Eli Lilly says it now plans to seek FDA approval in early 2027 for its next-generation weight-loss drug, retatrutide, following positive...

Author: NewsNation

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya